Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Cardiovascular Risk and DiseasesFurther Publications
Do you want to read an article? Please log in or register.